Atlas Trials

Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer

Clinical trial NCT06818149 · RECRUITING

Trial details

NCT number
NCT06818149
Sponsor
Shanghai Chest Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
Lung CancerMyocarditis Due to Drug
Start date
2025-01-30
Primary completion
2025-02-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.